The following decisions were made at the meeting, among others:

Adoption of annual accounts 
The AGM resolved to adopt the income statement and balance sheet for the Company and the Group for the financial year 2025.

Profit allocation 
The AGM resolved that the Company's results shall be carried forward and that no dividend shall be paid.

Discharge from liability 
The AGM granted discharge from liability for the Board members and the CEO for the financial year 2025.

Board of Directors and Auditors 
The AGM resolved that the Board of Directors shall consist of five members without deputies. The AGM resolved to re-elect Gustav Brismark, Emma Rönnmark, David Gramnaes, Oskar Säfström and Johan Rask as Board members. Oskar Säfström was re-elected as Chairman of the Board. The meeting further resolved that the board of directors shall be paid a fee of SEK 315,000 to the chairman of the board and SEK 157,500 to each of the other board members appointed by the meeting.

The auditing firm BDO Göteborg AB was re-elected as auditor for the period until the end of the next annual general meeting, with authorized public accountant Filip Laurin as the auditor in charge. The auditor's fee is paid according to an approved invoice.

Nomination Committee 
The meeting resolved to establish principles for the nomination committee in accordance with the nomination committee's proposal. The principles essentially correspond to those adopted at the 2025 annual general meeting, with certain editorial adjustments.

Amendment to the articles of association 
The meeting resolved to amend the articles of association. The amendment means that the limits for the share capital are changed to a minimum of SEK 21,538,283 and a maximum of SEK 86,153,132 and that the limits for the number of shares are changed to a minimum of SEK 180,799,125 and a maximum of SEK 723,196,500. Certain editorial changes were also decided.

Issuance authorization 
The meeting resolved to authorize the board of directors to, on one or more occasions during the period until the next annual general meeting, with or without deviation from the shareholders' preferential rights, decide on the issue of shares, warrants and/or convertibles. The authorization includes the right to decide on an issue with cash payment, payment with property in kind or payment by set-off and may otherwise be subject to the conditions referred to in Chapter 2, Section 5, second paragraph, 1–3 and 5 of the Swedish Companies Act. Warrants shall be issued free of charge. The number of shares that can be issued, or accrued after the exercise of warrants or conversion of convertibles, with the support of the authorization is limited to the limits of the articles of association applicable at any time for the share capital and the number of shares.

The purpose of the authorization, and the reason for any deviation from the shareholders' preferential rights, is to enable the acquisition of capital to meet the Company's capital needs, secure the Company's continued operations and development, enable acquisitions and to strengthen and/or broaden the Company's ownership base. The authorized authorization gives the Board the necessary flexibility to quickly carry out a capital acquisition in the form of an issue of shares, warrants and/or convertibles, if necessary, and thereby enable the Company to effectively act on emerging business opportunities or meet emerging needs in the business.

Full information and decisions 
All decisions were made in accordance with the proposals submitted to the meeting by the Board and the Nomination Committee. The proposals regarding the General Meeting's decisions are available on the Company's website, www.smoltek.com/investors/sv/arsstamma-2026 (in Swedish).

For further information:
Magnus Andersson, CEO of Smoltek Nanotech Holding AB
Email: magnus.andersson@smoltek.com  
Phone: +46 317 01 03 05
Website: www.smoltek.com/investors